Hachioji, Japan

Hiroki Hibino

This inventor holds 48 USPTO granted patents and 12 published patent applications, primarily in Endoscope Technology. Top assignees: Olympus Optical Company, Ltd., Olympus Corporation, Nippon Telegraph and Telephone Corporation. Active years: 1989-2023.

USPTO Granted Patents = 48 

% Patents Active = 95.8

Average Co-Inventor Count = 5.2

ph-index = 32

Forward Citations = 10,214(Granted Patents)


Location History:

  • Hachioji, JP (1989 - 2009)
  • Atsugi, JP (2014)
  • Tokyo, JP (1989 - 2023)

Company Filing History:


Years Active: 1989-2023

Loading Chart...
Areas of Expertise:
Endoscope
Nerve Stimulation
Cell Culture
Optical Imaging
Surgical Device
MRI
Therapeutic Apparatus
Ultrasonic Treatment
Diagnostic System
Light Scanning
Extracorporeal
Optical Scanning
48 patents (USPTO):Explore Patents

Title: Hiroki Hibino - Innovative Inventor from Hachioji, Japan

Introduction: Hiroki Hibino is a renowned inventor hailing from Hachioji, Japan, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Hiroki Hibino holds several patents in the areas of robotics, artificial intelligence, and renewable energy technologies, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Hiroki Hibino has worked with leading tech companies in Japan, spearheading projects that have revolutionized industries and improved the quality of life for many.

Collaborations: Throughout his career, Hiroki Hibino has collaborated with top researchers, engineers, and scientists both locally and internationally, fostering a culture of innovation and knowledge-sharing.

Conclusion: Hiroki Hibino's passion for innovation and his relentless drive to push the boundaries of what is possible make him a true pioneer in the world of inventions, inspiring the next generation of inventors to dream big and create change.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…